IP Library Granted Patent US 10,806,951
Granted Patent B2
US 10,806,951 · App. 14/843,108 · Granted Oct 20, 2020

Sonogenic stimulation of cells

Inventors: Sreekanth H. Chalasani (La Jolla, CA); Stuart Ibsen (La Jolla, CA)
Assignee: Salk Institute for Biological Studies
A61N7/00A61K41/0033C07K14/705C12N13/00A61B8/00A61K38/00A61N2007/0026G01N29/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,806,951
App. No.
14/843,108
Granted
Oct 20, 2020
Kind
B2
Abstract

The invention provides compositions featuring TRP-4 polypeptides and polynucleotides, methods for expressing such polypeptides and polynucleotides in a cell type of interest, and methods for inducing the activation of the TRP-4 polypeptide in neurons and other cell types using ultrasound.

Claims (53)

1. A method of rendering a cell responsive to mechanical deformation or stretch caused by ultrasound, the method comprising:

transducing a cell to express an exogenous, non-mammalian TRP-4 polypeptide,

contacting the cell with ultrasound; and

inducing cation influx in the TRP-4-expressing cell and an alteration in cell activity and/or function following said contact with ultrasound, thereby rendering the cell responsive to mechanical deformation or stretch caused by ultrasound.

2. The method of claim 1 , wherein said TRP-4 polypeptide comprises the amino acid sequence of SEQ ID NO: 1.

3. The method of claim 1 , wherein the cell is transduced using a vector comprising a polynucleotide sequence encoding the exogenous, non-mammalian TRP-4 polypeptide or using a recombinant nucleic acid molecule encoding the exogenous, non-mammalian TRP-4 polypeptide.

4. A method of inducing cation influx in a cell and sensitizing the cell to mechanical deformation or stretch caused by ultrasound, the method comprising:

transducing a cell to express an exogenous, non-mammalian mechanotransduction TRP-4 polypeptide;

applying ultrasound to the cell; and

inducing cation influx in the TRP-4-expressing cell and an alteration in cell activity and/or function following said application of ultrasound, thereby sensitizing the cell to said mechanical deformation or stretch caused by ultrasound.

5. The method of claim 4 , wherein said cell is a mammalian cell.

6. The method of claim 4 , wherein said cell is a bacterial cell.

7. The method of claim 4 , wherein said TRP-4 polypeptide is encoded by a polynucleotide codon-optimized for expression in the cell.

8. The method of claim 4 , wherein the cell is a muscle cell, a cardiac muscle cell, a neuron, a motor neuron, a sensory neuron, an interneuron, or an insulin secreting cell.

9. The method of claim 4 , wherein said ultrasound has a frequency of about 0.8 MHz to about 4 MHz.

10. The method of claim 4 , wherein said ultrasound has a focal zone of about 1 cubic millimeter to about 1 cubic centimeter.

11. The method of claim 4 , said method further comprising contacting the cell with a microbubble prior to applying ultrasound.

12. The method of claim 4 , wherein said cell is in vitro or in vivo.

13. The method of claim 4 , wherein the cell is transduced using a vector comprising a polynucleotide sequence encoding the exogenous, non-mammalian TRP-4 polypeptide or using a recombinant nucleic acid molecule encoding the exogenous, non-mammalian TRP-4 polypeptide.

14. A method of treating a disease or disorder in a subject in need thereof, said method comprising:

(i) transducing into a cell of a subject a heterologous nucleic acid molecule encoding a exogenous, non-mammalian mechanotransduction TRP-4 polypeptide, which is expressed in the cell;

(ii) applying ultrasound to the cell; and

(iii) inducing cation influx in the TRP-4-expressing cell and an alteration in cell activity and/or function following said application of ultrasound, thereby treating the disease or disorder in said subject.

15. The method of claim 14 , wherein said disease is a neurological disease selected from the group consisting of Parkinson Disease, depression, obsessive-compulsive disorder, chronic pain, epilepsy or cervical spinal cord injury.

16. The method of claim 14 , wherein said disorder is muscle weakness.

17. A method of activating or modifying cell activity or function, the method comprising:

transducing a cell to express an exogenous, non-mammalian mechanotransduction TRP-4 polypeptide;

applying focused ultrasound to the TRP-4 polypeptide-expressing cell;

inducing cation influx in the TRP-4-expressing cell and an alteration in cell activity and/or function following said application of ultrasound, thereby activating or modifying cell activity or function.

18. The method of claim 17 , wherein the cell is a mammalian cell.

19. The method of claim 17 , wherein the cell is a muscle cell, cardiac muscle cell, neuron, motor neuron, sensory neuron, interneuron, or insulin secreting cell.

20. The method of claim 17 , wherein said ultrasound has a frequency of about 0.8 MHz to about 4 MHz.

21. The method of claim 17 , wherein said ultrasound has a focal zone of about 1 cubic millimeter to about 1 cubic centimeter.

22. The method of claim 17 , wherein the cell is transduced using a vector comprising a polynucleotide sequence encoding the exogenous, non-mammalian TRP-4 polypeptide or using a recombinant nucleic acid molecule encoding the exogenous, non-mammalian TRP-4 polypeptide.

23. A method of sensitizing a neuron to mechanical deformation or stretch caused by ultrasound and activating and/or modifying activity or function of the neuron, the method comprising:

transducing a neuron to express an exogenous, non-mammalian mechanosensitive TRP-4 polypeptide;

applying ultrasound to the TRP-4 polypeptide-expressing neuron; and

inducing cation influx in the TRP-4-expressing neuron and an alteration in neuron activity and/or function following said application of ultrasound, thereby sensitizing the neuron to mechanical deformation or stretch caused by ultrasound and activating and/or modifying neuron activity or function.

24. The method of claim 23 , wherein the ultrasound is applied at a peak negative pressure level of less than about 0.5 MPa.

25. The method of claim 23 , wherein the neuron is a motor neuron, a sensory neuron, or an interneuron.

26. The method of claim 23 , wherein the neuron is transduced using a vector comprising a polynucleotide sequence encoding the exogenous, non-mammalian TRP-4 polypeptide or using a recombinant nucleic acid molecule encoding the exogenous, non-mammalian TRP-4 polypeptide.

27. A method of inducing cation influx in a cell and sensitizing the cell to mechanical deformation or stretch caused by ultrasound, the method comprising:

transducing a cell to express an exogenous, non-mammalian mechanotransduction TRP-N polypeptide;

applying ultrasound to the cell; and

inducing cation influx in the TRP-N-expressing cell and an alteration in cell activity and/or function following said application of ultrasound, thereby inducing cation influx into the cell and sensitizing the cell to mechanical deformation or stretch caused by ultrasound.

28. The method of claim 27 , wherein the exogenous, non-mammalian, mechanotransduction TRP-N polypeptide is TRP-4.

29. The method of claim 28 , wherein said TRP-4 polypeptide comprises the amino acid sequence of SEQ ID NO: 1.

30. The method of claim 27 , wherein the cell is a mammalian cell.

31. The method of claim 27 , wherein the cell is in vitro or in vivo.

32. The method of claim 27 , wherein the cell is a muscle cell, cardiac muscle cell, neuron, motor neuron, sensory neuron, interneuron, or insulin secreting cell.

33. The method of claim 27 , wherein said ultrasound has a frequency of about 0.8 MHz to about 4 MHz.

34. The method of claim 27 , wherein said ultrasound has a focal zone of about 1 cubic millimeter to about 1 cubic centimeter.

35. The method of claim 27 , wherein the cell is transduced using a vector comprising a polynucleotide sequence encoding the exogenous, non-mammalian TRP-N polypeptide or using a recombinant nucleic acid molecule encoding the exogenous, non-mammalian TRP-N polypeptide.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jun 23, 2016
From: SALK INSTITUTE FOR BIOLOGICAL STUDIES
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 039128/0662 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 5, 2015
From: CHALASANI, SREEKANTH H.; IBSEN, STUART
To: SALK INSTITUTE FOR BIOLOGICAL STUDIES
Reel/Frame 036967/0740 →
Continuity (2)
Provisional Application 62054600 · Sep 24, 2014
Related Publication 20160220672A1 · Aug 4, 2016